CN Patent
CN103788098A — 作为jak抑制剂的氮杂环丁烷和环丁烷衍生物
Assigned to Incyte Corp · Expires 2014-05-14 · 12y expired
What this patent protects
本发明涉及氮杂环丁烷和环丁烷衍生物以及它们的组合物及使用和制备方法,它们是可用于治疗包括例如炎性疾病和自身免疫疾病以及癌症的JAK相关性疾病的JAK抑制剂。
USPTO Abstract
本发明涉及氮杂环丁烷和环丁烷衍生物以及它们的组合物及使用和制备方法,它们是可用于治疗包括例如炎性疾病和自身免疫疾病以及癌症的JAK相关性疾病的JAK抑制剂。
Drugs covered by this patent
- Olumiant (baricitinib) · Eli Lilly
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.